Ferritin nanoparticle-based Nipah virus glycoprotein vaccines elicit potent protective immune responses in mice and hamsters
Virologica Sinica · 2024-12 · 39 (6) · 909-916
DOI: 10.1016/j.virs.2024.09.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Virologica Sinica, 2024-12. Verfasst von Shaohong Chen und 16 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, W…. Hauptthemen laut MEDLINE: Nipah Virus, Henipavirus Infections, Nanoparticles, Antibodies, Neutralizing. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of the Chinese Academy of Sciences, Chinese Academy of Sciences.
Abstract (Originalsprache)
Nipah virus (NiV) is a zoonotic paramyxovirus in the genus Henipavirus that is prevalent in Southeast Asia. NiV leads to severe respiratory disease and encephalitis in humans and animals, with a mortality rate of up to 75%. Despite the grave threat to public health and global biosecurity, no medical countermeasures are available for humans. Here, based on self-assembled ferritin nanoparticles (FeNPs), we successfully constructed two candidate FeNP vaccines by loading mammalian cells expressing NiV sG (residues 71-602, FeNP-sG) and Ghead (residues 182-602, FeNP-Ghead) onto E. coli-expressed FeNPs (FeNP-sG and FeNP-Ghead, respectively) through Spycatcher/Spytag technology. Compared with sG and Ghead alone, FeNP-sG and FeNP-Ghead elicited significant NiV specific neutralizing antibody levels and T-cell responses in mice, whereas the immune response in the FeNP-sG immunized group was greater than that in the FeNP-Ghead group. These results further demonstrate that sG possesses greater antigenicity than Ghead and that FeNPs can dramatically enhance immunogenicity. Furthermore, FeNP-sG provided 100% protection against NiV challenge in a hamster model when it was administered twice at a dose of 5 μg/per animal. Our study provides not only a promising candidate vaccine against NiV, but also a theoretical foundation for the design of a NiV immunogen for the development of novel strategies against NiV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430062, China; University of Chinese Academy of Sciences, Beijing…
- CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430062, China.
- Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.
- Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China; Key Laboratory of Anhui Province for Emerging and Reemerging Infectious Diseases, Hefei 230027, China.
- Institutional Center for Shared Technologies and Facilities of Wuhan Institute of Virology, CAS, Center for Instrumental Analysis and Metrology, Wuhan 430062, China.
- CAS Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430062, China. Electronic address: gongr@wh.iov.cn.
Förderung
- University of the Chinese Academy of Sciences
- Chinese Academy of Sciences
Zitieren
APA
Chen, S., Zhang, X., Yao, Y., Wang, S., Li, K., Zhang, B., Ye, T., Chen, L., Wu, Y., Li, E., Xu, B., Zhang, P., Chuai, X., Ran, Y., Gong, R., Zhang, H., & Chiu, S. (2024). Ferritin nanoparticle-based Nipah virus glycoprotein vaccines elicit potent protective immune responses in mice and hamsters. Virologica Sinica, 39(6), 909-916. https://doi.org/10.1016/j.virs.2024.09.005
Vancouver
Chen S, Zhang X, Yao Y, Wang S, Li K, Zhang B, et al. Ferritin nanoparticle-based Nipah virus glycoprotein vaccines elicit potent protective immune responses in mice and hamsters. Virologica Sinica. 2024;39(6):909-916. doi:10.1016/j.virs.2024.09.005
BibTeX
@article{Chen2024,
author = {Chen, Shaohong and Zhang, Xinghai and Yao, Yanfeng and Wang, Shengdong and Li, Kangyin and Zhang, Baoyue and Ye, Tianxi and Chen, Li and Wu, Yan and Li, Entao and Xu, Bichao and Zhang, Pei and Chuai, Xia and Ran, Yong and Gong, Rui and Zhang, Huajun and Chiu, Sandra},
title = {Ferritin nanoparticle-based Nipah virus glycoprotein vaccines elicit potent protective immune responses in mice and hamsters},
journal = {Virologica Sinica},
year = {2024},
volume = {39},
number = {6},
pages = {909--916},
doi = {10.1016/j.virs.2024.09.005}
}
EUVIMED